TERAPLAST SA financials
TERAPLAST SA
Country: RO Reporting currency: RON Latest annual report: 2022-12-31
LEI:
254900CX9UNGB7VM0R35 Financial statements
(RON, as reported — unscaled; 109 line items across 2 annual periods)
| Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Other income | RON 654.8K | RON 1.1M |
| Employee benefits expense | RON 83.6M | RON 69.3M |
| Raw materials & consumables used | RON 507.0M | RON 424.4M |
| Operating profit (EBIT) | RON 26.4M | RON 53.3M |
| Net finance income / (cost) | -RON 9.9M | -RON 2.3M |
| Profit before tax | RON 16.6M | RON 51.0M |
| Income tax expense | RON 1.2M | RON 8.7M |
| Profit for the year | RON 15.4M | RON 231.5M |
| Total comprehensive income | RON 16.5M | RON 237.0M |
| Cash flow statement | ||
| Net cash from operating activities | RON 30.1M | -RON 52.8M |
| Net cash from investing activities | -RON 57.7M | RON 277.0M |
| Net cash from financing activities | RON 30.6M | -RON 233.1M |
| Dividends paid | RON 32.7M | RON 226.6M |
| Repayments of borrowings | -RON 64.6M | RON 1.7M |
| Lease liability payments | RON 998.3K | RON 23.0K |
| Balance sheet | ||
| Total assets | RON 661.6M | RON 879.7M |
| Non-current assets | RON 366.8M | RON 296.3M |
| Property, plant & equipment | RON 338.1M | RON 278.3M |
| Right-of-use assets | RON 17.8M | RON 9.6M |
| Intangible assets & goodwill | RON 3.8M | RON 2.4M |
| Current assets | RON 294.8M | RON 583.4M |
| Inventories | RON 129.1M | RON 118.1M |
| Trade & other receivables | RON 146.3M | RON 171.6M |
| Cash & equivalents | RON 10.7M | RON 7.7M |
| Total equity | RON 309.5M | RON 591.5M |
| — attributable to owners | RON 306.2M | RON 587.9M |
| Non-controlling interests | RON 3.3M | RON 3.7M |
| Non-current liabilities | RON 111.5M | RON 90.3M |
| Long-term borrowings | RON 38.8M | RON 39.5M |
| Lease liabilities (non-current) | RON 5.9M | RON 6.5M |
| Current liabilities | RON 240.5M | RON 197.9M |
| Short-term borrowings | RON 151.8M | RON 86.5M |
| Lease liabilities (current) | RON 2.1M | RON 2.0M |
| Trade & other payables | RON 79.5M | RON 103.8M |
| Deferred tax liabilities | RON 0 | RON 991.6K |
| Derived metrics | ||
| Operating margin | 3.7% | 8.7% |
| Net margin | 2.2% | 37.6% |
| Return on equity | 5.0% | 39.1% |
| Cash conversion ratio | 1.96× | -0.23× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -RON 12.6M | -RON 52.0M |
| Adjustments For Decrease Increase In Trade Account Receivable | RON 21.2M | -RON 90.9M |
| Adjustments For Dividend Income | RON 55.7K | RON 79.7K |
| Adjustments For Gains Losses On Fair Value Adjustment Investment Property | RON 559.2K | RON 669.0K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Inventories | RON 1.5M | -RON 1.0M |
| Adjustments For Increase Decrease In Trade and Other Payables | -RON 23.5M | RON 29.0M |
| Adjustments For Interest Expense | RON 9.9M | RON 1.6M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -RON 86.8K | -RON 214.9K |
| Adjustments For Provisions | -RON 320.9K | RON 2.2M |
| Basic Earnings Loss Per Share From Continuing Operations | — | RON 0.02 |
| Cancellation of Treasury Shares | — | -RON 4.9M |
| Cash | RON 10.7M | RON 7.7M |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | RON 0 | RON 384.9M |
| Cash Flows From Used In Operations Before Changes In Working Capital | RON 62.3M | RON 75.7M |
| Changes In Inventories of Finished Goods and Work In Progress | -RON 20.5M | -RON 17.9M |
| Comprehensive Income Attributable To Noncontrolling Interests | -RON 389.1K | -RON 358.9K |
| Comprehensive Income Attributable To Owners of Parent | RON 16.8M | RON 237.4M |
| Current Advances To Suppliers | RON 7.4M | RON 15.3M |
| Current Dividend Payables | RON 45.5K | RON 45.5K |
| Current Government Grants | RON 5.4M | RON 2.6M |
| Current Prepaid Expenses | RON 825.6K | RON 615.1K |
| Current Tax Assets Current | RON 415.7K | RON 0 |
| Current Tax Liabilities Current | RON 0 | RON 278.4K |
| Deferred Tax Assets | RON 298.1K | RON 0 |
| Diluted Earnings Loss Per Share From Continuing Operations | — | RON 0.02 |
| Dividends Recognised As Distributions To Owners of Parent Relating To Current Year | RON 32.7M | — |
| Dividends Recognised As Distributions To Owners of Parent Relating To Prior Years | RON 270.2M | RON 30.7M |
| Dividends Recognised As Distributions To Owners Per Share | RON 0.01 | — |
| Equity and Liabilities | RON 661.6M | RON 879.7M |
| Finance Income | RON 26.7K | RON 365.5K |
| Income Tax Relating To Components of Other Comprehensive Income | RON 281.7K | RON 1.0M |
| Income Taxes Paid Refund Classified As Operating Activities | RON 3.2M | RON 10.6M |
| Increase Decrease In Cash and Cash Equivalents | RON 3.0M | -RON 8.9M |
| Increase Decrease Through Sharebased Payment Transactions | RON 4.4M | — |
| Increase Decrease Through Transfer Between Revaluation Reserve and Retained Earnings | RON 1.4M | RON 9.6M |
| Increase Decrease Through Transfer To Statutory Reserve | RON 0 | RON 0 |
| Increase Decrease Through Transfers and Other Changes Equity | -RON 1.1M | RON 2.8M |
| Interest Expense | RON 9.9M | RON 1.6M |
| Interest Paid Classified As Operating Activities | RON 9.9M | RON 1.6M |
| Investment Property | RON 4.9M | RON 4.4M |
| Issue of Equity | — | RON 43.6M |
| Issued Capital | RON 217.9M | RON 217.9M |
| Liabilities | RON 352.1M | RON 288.2M |
| Net Foreign Exchange Loss | RON 85.2K | RON 1.2M |
| Noncurrent Government Grants | RON 55.1M | RON 31.8M |
| Noncurrent Provisions For Employee Benefits | RON 2.0M | RON 1.9M |
| Noncurrent Receivables | RON 1.8M | RON 1.6M |
| Other Comprehensive Income | RON 1.1M | RON 5.5M |
| Other Comprehensive Income Before Tax Gains Losses On Revaluation | RON 1.4M | RON 6.5M |
| Other Expense By Nature | RON 31.1M | RON 24.8M |
| Other Noncurrent Financial Assets | RON 15.5K | RON 15.5K |
| Other Noncurrent Liabilities | RON 8.4M | RON 9.0M |
| Other Reversals of Provisions | RON 320.9K | -RON 2.2M |
| Other Shortterm Provisions | RON 952.6K | RON 2.2M |
| Proceeds From Government Grants Classified As Investing Activities | RON 30.4M | RON 16.9M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | RON 2.5M | RON 2.6M |
| Profit Loss From Continuing Operations | RON 15.4M | RON 42.3M |
| Profit Loss From Discontinued Operations | RON 0 | RON 189.2M |
| Retained Earnings | RON 36.3M | RON 325.7M |
| Revaluation Surplus | RON 17.3M | RON 15.9M |
| Revenue From Contracts With Customers | RON 711.1M | RON 615.1M |
| Revenue From Dividends | RON 55.7K | RON 79.7K |
| Revenue From Government Grants | RON 4.3M | RON 2.4M |
| Revenue From Rendering of Services | RON 5.3M | RON 2.3M |
| Sale Or Issue of Treasury Shares | -RON 411.1K | — |
| Statutory Reserve | RON 35.2M | RON 33.3M |
| Transportation Expense | RON 29.7M | RON 22.3M |
| Treasury Shares | RON 495.2K | RON 4.9M |
| Utilities Expense | RON 21.1M | RON 17.5M |
| Weighted Average Shares | 2179.0M | 1888.5M |
Methodology
Every line item above is a fact tagged in TERAPLAST SA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (RON), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.